-The Economic Times NEW DELHI: US business leader and philanthropist Bill Gates met Planning Commission deputy chairman Montek Singh Ahluwalia on Wednesday to discuss healthcare issues, including India's low healthcare expenditure. "There were discussions on healthcare and vaccination. He appreciated the progress in immunization programme in India," a senior planning commission official told ET. India's 12th Five Year plan has projected to increase healthcare spending to 2.5% of GDP compared to little...
More »SEARCH RESULT
Total Matching Records found : 1618
Aruna Roy upset over minimum wages issue-Smita Gupta
-The Hindu How a country like India can deny payment of minimum wages, she asks For the second time since it was created, rights activist Aruna Roy has resigned from the Sonia Gandhi-led National Advisory Council (NAC), this time criticising the government for not accepting the council's recommendations on minimum wages to workers under the Mahatma Gandhi National Rural Employment Guarantee Scheme (MGNREGS), even as she thanked the council's chairperson for the...
More »Govt wants checks for pesticides in food
-The Times of India NEW DELHI: A Central government panel has recommended stringent checks for pesticides in fruits and vegetables, including imported ones. Submitting a report before a bench comprising Chief Justice D Murugesan and Justice Jayant Nath on Wednesday, the panel - led by a health ministry official - is for intensive monitoring of pesticide residues on fruits and vegetables sold in Delhi. The experts committee, chaired by Sandhya Kulshrestha, was...
More »The continuing tragedy of the adivasis-Ramachandra Guha
-The Hindu The killings of Mahendra Karma and his colleagues call not for retributive violence but for a deeper reflection on the discontent among the tribals of central India and their dispossession In the summer of 2006, I had a long conversation with Mahendra Karma, the Chhattisgarh Congress leader who was killed in a terror attack by the Naxalites last week. I was not alone - with me were five other members...
More »USFDA scrutiny: Will pharma majors like Ranbaxy, Wockhardt be affected in long-term? -G Seetharaman
-The Economic Times Japanese companies do not mind erring on the side of caution. They are known to think longer and harder than their counterparts in other countries about big decisions, especially when it comes to entering a new market or acquiring a foreign company. But Japan's third biggest drugmaker Daiichi Sankyo would now wish it had spent more time doing due diligence on Ranbaxy Labs, in which it bought a...
More »
